Macpred 1g contains Methylprednisolone 1 gram, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of severe inflammatory and autoimmune conditions, including acute exacerbations of multiple sclerosis, severe allergic reactions, and certain types of arthritis. Methylprednisolone acts by modulating the immune response through inhibition of multiple inflammatory cytokines, thereby reducing tissue inflammation and immune-mediated damage. The drug is administered intravenously or intramuscularly in acute settings requiring rapid therapeutic effect. Dosage and duration of therapy depend on the specific condition being treated, patient response, and clinical judgment. Common adverse effects may include hyperglycemia, fluid retention, hypertension, and increased susceptibility to infections. Long-term use necessitates monitoring for potential complications such as adrenal suppression, osteoporosis, and gastrointestinal disturbances. Macpred 1g should be used with caution in patients with diabetes, hypertension, peptic ulcer disease, or systemic infections. Abrupt discontinuation after prolonged therapy is contraindicated due to risk of adrenal insufficiency; tapering is recommended. This medication should be prescribed and administered under strict medical supervision, ensuring appropriate patient evaluation and monitoring throughout the treatment course.